HUATF yields 3.48% · JNJ yields 2.13%● Live data
📍 HUATF pulled ahead of the other in Year 1
Combined, HUATF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HUATF + JNJ for your $10,000?
Huatai Securities Co., Ltd., a security company, provides financial services in Mainland China and internationally. The company buys and sells stocks, funds, bonds, futures, and options on behalf of clients; and provides various financial products and asset allocation, margin financing, securities lending, securities-backed lending, and margin securities lending services. It also offers institutional investment banking services, such as equity and bond underwriting, financial consultancy, and over-the-counter business services for enterprises, institutions, and governments; cross-border proprietary and credit derivative products and services; custodian and fund services, including settlement, liquidation, reporting, and valuation services, as well as margin trading and other value-added services to various asset management institutions; and professional research and consulting services. In addition, the company provides private equity fund and asset management services for securities and futures companies, funds, etc. Huatai Securities Co., Ltd. was founded in 1990 and is headquartered in Nanjing, the People's Republic of China.
Full HUATF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.